Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer
Open Access
- 14 June 2017
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (12), 3317-3324
- https://doi.org/10.1158/0008-5472.can-16-3478
Abstract
The presence of tumor-infiltrating lymphocytes (TIL) is a favorable prognostic factor in breast cancer, but what drives immune infiltration remains unknown. Here we examine if clonal heterogeneity, total mutation load, neoantigen load, copy number variations (CNV), gene- or pathway-level somatic mutations, or germline polymorphisms (SNP) are associated with immune metagene expression in breast cancer subtypes. Thirteen published immune metagenes correlated separately with genomic metrics in the 3 major breast cancer subtypes. We analyzed RNA-Seq, DNA copy number, mutation and germline SNP data of 627 ER positive, 207 HER2 positive, and 191 triple negative (TNBC) cancers from TCGA. P-values were adjusted for multiple comparisons, and permutation testing was used to assess false discovery rates. Increased immune metagene expression associated significantly with lower clonal heterogeneity estimated by MATH score in all subtypes and with a trend for lower overall mutation, neoantigen, and CNV loads in TNBC and HER2+ cancers. In ER+ cancers, mutation load, neoantigen load, and CNV load weakly but positively associated with immune infiltration, which reached significance for overall mutation load only. No highly recurrent single gene or pathway level mutations associated with immune infiltration. High immune gene expression and lower clonal heterogeneity in TNBC and HER2+ cancers suggest an immune pruning effect and equilibrium between immune surveillance and clonal expansion. Thus, immune checkpoint inhibitors may tip the balance in favor of immune surveillance in these cancers.Keywords
Other Versions
This publication has 40 references indexed in Scilit:
- Identification of genomic functional hotspots with copy number alteration in liver cancerEURASIP Journal on Bioinformatics and Systems Biology, 2013
- Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated PathwayCell, 2013
- Dimerization of complement factor H-related proteins modulates complement activation in vivoProceedings of the National Academy of Sciences of the United States of America, 2013
- T-Regulatory Cells: Key Players in Tumor Immune Escape and AngiogenesisCancer Research, 2012
- Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences of the United States of America, 2010
- Deriving the consequences of genomic variants with the Ensembl API and SNP Effect PredictorBioinformatics, 2010
- Altered peptide ligands of myelin basic protein (MBP87–99) conjugated to reduced mannan modulate immune responses in miceImmunology, 2009
- Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem CellsCancer Research, 2009
- Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary resultsVaccine, 2008
- The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cellsThe Journal of Experimental Medicine, 2006